USClinicalTrials.govClinical trial
A Phase 1 Study of the Safety and Tolerability of CTX-10726
Phase 1RecruitingJul 31, 2026
Cancer types
Liver Cancer
Incl. hepatocellular carcinoma (HCC). 62 official records currently indexed across three regions.
Trial records retrieved live from the ClinicalTrials.gov public API.
Showing 62 of 62
Highlight terms:
USEUOTHERClinicalTrials.govClinical trial
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Phase 3RecruitingJul 31, 2026
OTHERClinicalTrials.govClinical trial
A Post Approval Study to Evaluate Safety and Effectiveness of Multicompartmental Dosimetry Planning.
Not yet recruitingJul 31, 2026
USEUCNOTHERClinicalTrials.govClinical trial
A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation
Phase 3Active, not recruitingJul 31, 2026
USClinicalTrials.govClinical trial
Combined Y-90 Selective Internal Radiation Therapy (Y-90 SIRT) and Stereotactic Body Radiation Therapy (SBRT) in Hepatic Malignancy.
Phase 1Active, not recruitingJul 31, 2026
USClinicalTrials.govClinical trial
Getting To Implementation: Improving Cancer Screening for Veterans
Not applicableEnrolling by invitationJul 31, 2026
USClinicalTrials.govClinical trial
Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy
Phase 1Not yet recruitingJul 31, 2026
OTHERClinicalTrials.govClinical trial
Neoantigen Dendritic Cell Vaccine and Nivolumab in HCC and Liver Metastases From CRC
Phase 2RecruitingJul 31, 2026
USOTHERClinicalTrials.govClinical trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Phase 2Active, not recruitingJul 31, 2026
USClinicalTrials.govClinical trial
Testing the Addition of an Anti-cancer Drug, Sapanisertib, to the Usual Chemotherapy Treatment (Cabozantinib) in Metastatic Liver Cell Cancer With a Change in Genes for the Protein β-Catenin, The SAPHIRE Trial
Phase 1/2RecruitingJul 31, 2026
USClinicalTrials.govClinical trial
Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the Liver
Phase 2Active, not recruitingJul 31, 2026
USClinicalTrials.govClinical trial
Testing the Combination of the Anticancer Drug Durvalumab With Chemotherapy (Gemcitabine and Cisplatin) at Improving Outcomes for High-Risk Resectable Liver Cancer Before Surgery
Phase 2RecruitingJul 31, 2026
USEUClinicalTrials.govClinical trial
TheraSphere With Durvalumab and Tremelimumab for HCC
Phase 2Active, not recruitingJul 31, 2026
CNClinicalTrials.govClinical trial
TITAN-HCC: Neoadjuvant and Adjuvant QL1706 With TACE in Resectable Hepatocellular Carcinoma Beyond Milan Criteria
Not applicableRecruitingJul 31, 2026
USClinicalTrials.govClinical trial
Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
Phase 1Active, not recruitingJul 31, 2026
USEUCNClinicalTrials.govClinical trial
A Study of Nofazinlimab (CS1003) in Subjects With Advanced Hepatocellular Carcinoma
Phase 3Active, not recruitingJul 30, 2026
OTHERClinicalTrials.govClinical trial
Biomarker Panel for PCOS-Associated Liver Steatosis in Adolescent Girls (COMPASS-pedPCOS)
Not yet recruitingJul 30, 2026
OTHERClinicalTrials.govClinical trial
Managing Hepatitis B (Hep. B) and Human Papilloma Virus (HPV) Related Cancers and Mental Health.
Phase 4Not yet recruitingJul 30, 2026
USClinicalTrials.govClinical trial
Phase I/II Randomized Study of NBTXR3 Activated by Abscopal or RadScopal Radiation in Combination With Immunotherapy (Anti-PD-1/L-1) for Patients With Advanced Solid Malignancies
Phase 1/2RecruitingJul 30, 2026
USEUOTHERClinicalTrials.govClinical trial
Safety of HRX215 in Patients After Minor and Major Liver Resection
Phase 1/2RecruitingJul 30, 2026
OTHERClinicalTrials.govClinical trial
Study on the Combined Treatment of Hepatocellular Carcinoma With Envafolimab, Suvemcitug and HAIC Conversion
Not applicableNot yet recruitingJul 30, 2026
USClinicalTrials.govClinical trial
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Phase 2RecruitingJul 30, 2026
USEUCNOTHERClinicalTrials.govClinical trial
A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors
Phase 1RecruitingJul 29, 2026
CNOTHERClinicalTrials.govClinical trial
A Study of TACE Combined With Atezolizumab Plus Bevacizumab or TACE Alone in Patients With Untreated Heaptocellular Carcionma
Phase 3Active, not recruitingJul 29, 2026
CNClinicalTrials.govClinical trial
AI-Guided Surveillance and Curative Salvage of Recurrence After Hepatocellular Carcinoma Resection or Ablation
Not applicableNot yet recruitingJul 29, 2026
USClinicalTrials.govClinical trial
Analysis of Breath Volatile Organic Compounds Using Mass Spectrometry
Not yet recruitingJul 29, 2026
OTHERClinicalTrials.govClinical trial
Ebastine for Adjuvant Treatment of Tumor Budding-Positive Liver Cancer After Surgery
Phase 4Not yet recruitingJul 29, 2026
CNClinicalTrials.govClinical trial
HAIC or Lenvatinib Combined With Sintilimab for High Recurrence Risk Resectable Solitary Hepatocellular Carcinoma
Not applicableActive, not recruitingJul 29, 2026
USClinicalTrials.govClinical trial
Hepzato Kit and Opdualag for Metastatic Melanoma and Liver Metastasis
Phase 1/2RecruitingJul 29, 2026
OTHERClinicalTrials.govClinical trial
Peripheral Blood Biomarkers and Response to Atezolizumab Plus Bevacizumab in Hepatocellular Carcinoma
Not yet recruitingJul 29, 2026
USCNOTHERClinicalTrials.govClinical trial
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
Phase 1RecruitingJul 29, 2026
CNClinicalTrials.govClinical trial
YMN-136 Vaccine for Patients With Liver Metastasis of Colorectal Cancer Progressing After Third-Line Treatment
Phase 1RecruitingJul 29, 2026
USClinicalTrials.govClinical trial
A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
Phase 1RecruitingJul 28, 2026
USClinicalTrials.govClinical trial
Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution
Phase 4Active, not recruitingJul 28, 2026
USClinicalTrials.govClinical trial
Atezolizumab and Bevacizumab in Combination With Y^90 Radioembolization in HCC for Liver Transplant
Phase 4RecruitingJul 28, 2026
USClinicalTrials.govClinical trial
Collection of Blood From Patients With Cancer
RecruitingJul 28, 2026
USClinicalTrials.govClinical trial
Cryoablation and Arterial Infusion of SD-101 in Combination With Durvalumab and Tremelimumab
Phase 1Active, not recruitingJul 28, 2026
OTHERClinicalTrials.govClinical trial
CT Volumetry and Hepatic Vascular Deformation Mapping to Predict Post-Hepatectomy Liver Failure
Not yet recruitingJul 28, 2026
USOTHERClinicalTrials.govClinical trial
DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection
Phase 1Active, not recruitingJul 28, 2026
CNClinicalTrials.govClinical trial
MRG006A Combination Therapy for Advanced Hepatocellular Carcinoma (Phase I/II)
Phase 1/2RecruitingJul 28, 2026
CNCDERegulatory
CDE 临床试验默示许可 — clinical trial implied licence notices
Continuously updated
CNCDERegulatory
CDE 优先审评公示 — priority review listings
Continuously updated
CNCDERegulatory
CDE 受理品种信息 — applications accepted for review
Continuously updated
CNCDEGuideline
CDE 指导原则 — published technical guidance documents
Continuously updated
CNCDERegulatory
CDE 突破性治疗公示 — breakthrough therapy designation notices
Continuously updated
CNCDERegulatory
CDE 附条件批准品种 — conditionally approved products list
Continuously updated
CNChiCTRRegistry
ChiCTR — Chinese Clinical Trial Registry, public search
Continuously updated
EUCTISRegistry
CTIS public register — search clinical trials authorised in the EU/EEA
Continuously updated
EUEMARegulatory
EMA — CHMP meeting highlights and opinions on new medicines
Continuously updated
EUEMARegulatory
EMA — medicines for human use currently under evaluation (monthly CHMP list)
Continuously updated
EUEMARegulatory
EMA — searchable database of authorised medicines in the EU
Continuously updated
EUESMOGuideline
ESMO Clinical Practice Guidelines — gastrointestinal cancers
Continuously updated
EUESMOGuideline
ESMO Clinical Practice Guidelines — public index by tumour type
Continuously updated
EUESMOGuideline
ESMO Clinical Practice Guidelines — supportive and palliative care section
Continuously updated
USFDARegulatory
FDA — expanded access (compassionate use) information for patients
Continuously updated
USFDARegulatory
FDA — oncology (cancer) / hematologic malignancies approval notifications
Continuously updated
USFDARegulatory
FDA — ongoing accelerated approvals for oncology indications
Continuously updated
USNCCNGuideline
NCCN Guidelines — palliative care category listing
Continuously updated
USNCCNGuideline
NCCN Guidelines — public index by cancer type (free registration)
Continuously updated
USNCCNGuideline
NCCN Guidelines for Patients — plain-language versions
Continuously updated
CNNMPARegulatory
NMPA 药品 — national drug approval announcements
Continuously updated
CNCDERegistry
药物临床试验登记与信息公示平台 — national registry of drug trials conducted in China
Continuously updated
This site does not provide medical advice
TrialBeacon only aggregates links to publicly available official information. It does not recommend, rank or evaluate any treatment, trial or medicine, and nothing here implies suitability for any individual. Please discuss anything you find with your treating doctor, and always rely on the original official page — records change over time. Full disclaimer.